High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$19.7M
$19,712,048
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-11 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.8%
2026-03-11
$652,390
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.8%
|
2026-03-11 | $652,390 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -39.2%
2026-03-11
$638,631
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -39.2%
|
2026-03-11 | $638,631 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -73.0%
2026-03-11
$631,276
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -73.0%
|
2026-03-11 | $631,276 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.8%
2026-03-11
$595,040
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.8%
|
2026-03-11 | $595,040 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.6%
2026-03-11
$590,121
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.6%
|
2026-03-11 | $590,121 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.9%
2026-03-11
$509,664
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.9%
|
2026-03-11 | $509,664 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.5%
2026-03-11
$453,658
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.5%
|
2026-03-11 | $453,658 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $441,512 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $191,566 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.8%
2026-03-11
$163,428
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.8%
|
2026-03-11 | $163,428 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.1%
2026-03-11
$130,328
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.1%
|
2026-03-11 | $130,328 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $128,032 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-10 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.9%
2026-03-10
$729,322
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.9%
|
2026-03-10 | $729,322 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.3%
2026-03-10
$706,321
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.3%
|
2026-03-10 | $706,321 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -45.3%
2026-03-10
$510,169
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -45.3%
|
2026-03-10 | $510,169 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -28.5%
2026-03-10
$448,290
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -28.5%
|
2026-03-10 | $448,290 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $424,024 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $348,036 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $303,470 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.2%
2026-03-10
$304,013
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.2%
|
2026-03-10 | $304,013 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -42.5%
2026-03-10
$262,180
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -42.5%
|
2026-03-10 | $262,180 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $246,019 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.3%
2026-03-10
$237,877
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.3%
|
2026-03-10 | $237,877 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.5%
2026-03-10
$218,855
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.5%
|
2026-03-10 | $218,855 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.4%
2026-03-10
$216,676
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.4%
|
2026-03-10 | $216,676 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.0%
|
2026-03-10 | $65,772 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $63,658 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $21,329 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $21,262 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-09 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -54.5%
2026-03-09
$562,797
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -54.5%
|
2026-03-09 | $562,797 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.6%
2026-03-09
$458,514
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.6%
|
2026-03-09 | $458,514 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $358,075 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -76.3%
2026-03-09
$358,561
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -76.3%
|
2026-03-09 | $358,561 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.8%
2026-03-09
$349,720
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.8%
|
2026-03-09 | $349,720 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $347,226 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $309,269 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.6%
2026-03-09
$303,785
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.6%
|
2026-03-09 | $303,785 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $290,919 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.7%
2026-03-09
$270,396
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.7%
|
2026-03-09 | $270,396 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.2%
2026-03-09
$242,203
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.2%
|
2026-03-09 | $242,203 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $187,286 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.9%
2026-03-09
$174,878
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.9%
|
2026-03-09 | $174,878 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $165,187 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $124,317 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.9%
2026-03-09
$126,384
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.9%
|
2026-03-09 | $126,384 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $100,010 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $86,381 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $62,982 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.1%
|
2026-03-09 | $42,386 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-06 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -35.9%
2026-03-06
$1,047,699Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -35.9%
|
2026-03-06 | $1,047,699Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.0%
2026-03-06
$579,723
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.0%
|
2026-03-06 | $579,723 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.8%
2026-03-06
$531,449
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.8%
|
2026-03-06 | $531,449 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.0%
2026-03-06
$474,596
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.0%
|
2026-03-06 | $474,596 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -44.3%
2026-03-06
$450,681
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -44.3%
|
2026-03-06 | $450,681 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.6%
2026-03-06
$419,202
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.6%
|
2026-03-06 | $419,202 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -21.6%
2026-03-06
$279,144
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.6%
|
2026-03-06 | $279,144 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.8%
2026-03-06
$217,659
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.8%
|
2026-03-06 | $217,659 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $134,038 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $114,049 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.3%
2026-03-06
$115,582
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.3%
|
2026-03-06 | $115,582 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.3%
|
2026-03-06 | $96,547 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.2%
|
2026-03-06 | $77,483 | S | Form 4 |